ResearchMoz

Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators

GBI Research
Published Date » 2011-09-15
No. Of Pages » 120

GBI Researchs report, Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators provides key data, information and analysis on the global drug delivery device market. The report provides the market landscape, competitive landscape and market trend information on four drug delivery device market categories, namely central venous catheters, infusion systems, metered dose inhaler devices and needle-free injections. 

The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. The report also reviews the details of important merger and acquisition deals that have taken place in the drug delivery device market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Market size and company share data for four drug delivery device market categories - central venous catheters, infusion systems, metered dose inhaler devices and needle-free injections.
  • Annualized market revenues data from 2003 to 2010 and the forecast to 2017. Company share data for 2010 has been given for all categories.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the drug delivery device market.
  • The report also covers information on the leading market players, the competitive landscape and leading technology.
  • Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Hospira, Inc, CareFusion Corporation, Baxter International Inc, Teleflex Incorporated and INJEX - Equidyne Systems.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the drug delivery device market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
  • What is the next big thing in the drug delivery device market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global drug delivery device market and the factors shaping it.
Table of Contents

1 Table of Contents

1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 10
2.1 GBI Research Guidance 10

3 Drug Delivery Devices - Market Characterization 11
3.1 Global Drug Delivery Device Market, Revenue ($m), 2003-2010 11
3.2 Global Drug Delivery Device Market, Revenue Forecast ($m), 2010-2017 12
3.3 Global Drug Delivery Device Market, Key Technology Trends 13
3.3.1 Future Applications of Nano-Enabled Drug Delivery 13
3.3.2 Increased Application of Microneedle Enhanced Drug Delivery to Include Skin Cancer 15
3.3.3 Smart Infusion Pumps Equipped with Computerized Prescriber Order Entry (CPOE), and Bar-Coded Medication Administration (BCMA) Prevent Medication Errors 15
3.3.4 Specialized Drug Delivery Systems to Deliver Biologics and Biotech Compounds will Augment Market Growth 15
3.3.5 Transcutaneous Immunization (TCI) - Needle-Free Drug Delivery Technology used as Immunostimulant 16
3.4 Global Drug Delivery Device Market, Market Dynamics 17
3.4.1 Market Drivers 17
3.4.2 Market Restraints 20
3.5 Global Drug Delivery Device Market, Key Company Share (%), 2010 22

4 Global Drug Delivery Device Market - Category Analysis and Forecasts 23
4.1 Drug Delivery Devices 23
4.2 Central Venous Catheters 23
4.2.1 Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
4.2.2 Central Venous Catheter Market, Global, Revenue Forecast ($m), 2010-2017 25
4.2.3 Central Venous Catheters - Market Dynamics 26
4.2.4 Market Drivers 26
4.2.5 Market Restraints 27
4.2.6 Central Venous Catheter Market, Global, Company Share (%), 2010 29
4.3 Infusion Systems 30
4.3.1 Infusion System Market, Global, Revenue ($m), 2003-2010 30
4.3.2 Infusion System Market, Global, Revenue Forecast ($m), 2010-2017 31
4.3.3 Infusion Systems - Market Dynamics 32
4.3.4 Market Drivers 32
4.3.5 Market Restraints 34
4.3.6 Infusion System Market, Global, Company Share (%), 2010 37
4.4 Metered Dose Inhaler Devices 38
4.4.1 Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
4.4.2 Metered Dose Inhaler Device Market, Global, Revenue Forecasts ($m), 2010-2017 39
4.4.3 Metered Dose Inhaler Devices - Market Dynamics 40
4.4.4 Market Drivers 40
4.4.5 Market Restraints 42
4.4.6 Metered Dose Inhaler Device Market, Global, Company Share (%), 2010 43
4.5 Needle-Free Injections 44
4.5.1 Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 44
4.5.2 Needle-Free Injection Market, Global, Revenue Forecasts ($m), 2010-2017 46
4.5.3 Needle-Free Injections - Market Dynamics 47
4.5.4 Market Drivers 47
4.5.5 Market Restraints 49
4.5.6 Needle-Free Injection Market, Global, Company Share (%), 2010 50

5 Global Drug Delivery Device Market - Country Analysis and Forecasts 51
5.1 Drug Delivery Device Market - Cross-Country Analysis 51
5.2 Revenue Forecasts, By Country, 2003-2017 52
5.2.1 Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
5.2.2 Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
5.2.3 Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
5.2.4 Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
5.2.5 Drug Delivery Device Market, UK, Revenue ($m), 2003-2010 56
5.2.6 Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
5.2.7 Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
5.2.8 Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
5.2.9 Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
5.2.10 Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
5.2.11 Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
5.2.12 Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
5.2.13 Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
5.2.14 Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
5.2.15 Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
5.2.16 Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
5.2.17 Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
5.2.18 Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
5.2.19 Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
5.2.20 Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
5.2.21 Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
5.2.22 Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
5.2.23 Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
5.2.24 Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75

6 Global Drug Delivery Device Market - Competitive Assessment 76
6.1 Drug Delivery Devices, Market Opportunities and Risk Evaluation 76
6.2 GlaxoSmithKline plc 78
6.2.1 Business Overview 78
6.2.2 Key Products 78
6.3 Boehringer Ingelheim GmbH 79
6.3.1 Business Overview 79
6.3.2 Key Products 80
6.4 AstraZeneca plc 81
6.4.1 Business Overview 81
6.4.2 Key Products 82
6.5 Hospira, Inc. 83
6.5.1 Business Overview 83
6.5.2 Key Products 84
6.6 CareFusion Corporation 85
6.6.1 Business Overview 85
6.6.2 Key Products 86
6.7 Baxter International Inc. 87
6.7.1 Business Overview 87
6.7.2 Key Products 88
6.8 Teleflex Incorporated 88
6.8.1 Business Overview 88
6.8.2 Key Products 89
6.9 INJEX - Equidyne Systems 90
6.9.1 Business Overview 90
6.9.2 Key Products 90

7 Drug Delivery Device Market - Pipeline Product Analysis 91
7.1 Drug Delivery Devices - Pipeline Product Summary 91
7.2 Injectable Drug Delivery 92
7.2.1 Injectable Drug Delivery - List of Pipeline Products 92
7.2.2 Injectable Drug Delivery - Profiles of Key Pipeline Products 94
7.3 Metered Dose Inhalers 95
7.3.1 Metered Dose Inhalers - List of Pipeline Products 95
7.3.2 Metered Dose Inhalers - Profiles of Key Pipeline Products 95
7.4 Infusion Systems 96
7.4.1 Infusion Systems - List of Pipeline Products 96
7.4.2 Infusion Systems - Profiles of Key Pipeline Products 97
7.5 Needle-Free Injections 98
7.5.1 Needle-Free Injections - List of Pipeline Products 98
7.5.2 Needle-Free Injections - Profiles of Pipeline Products 98
7.6 Peripherally Inserted Central Catheter 99
7.6.1 Peripherally Inserted Central Catheter - List of Pipeline Products 99
7.6.2 Peripherally Inserted Central Catheter - Profiles of Key Pipeline Products 99
7.7 Transdermal Drug Delivery Devices 100
7.7.1 Transdermal Drug Delivery Devices - List of Pipeline Products 100
7.7.2 Transdermal Drug Delivery Devices - Profiles of Key Pipeline Products 102
7.8 Transmucosal Drug Delivery Devices 103
7.8.1 Transmucosal Drug Delivery Devices - List of Pipeline Products 103
7.8.2 Transmucosal Drug Delivery - Profiles of Key Pipeline Products 104
7.9 Inhalable Drug Delivery Devices 105
7.9.1 Inhalable Drug Delivery Devices - List of Pipeline Products 105
7.9.2 Inhalable Drug Delivery - Profiles of Key Pipeline Products 106
7.10 Niche Technologies 107
7.10.1 Niche Technologies - List of Pipeline Products 107
7.10.2 Niche Technologies - Profiles of Key Pipeline Products 108

8 Global Drug Delivery Device Market - Consolidation Landscape 109
8.1 Deals by Count, 2007-2010 109
8.2 Key Deals in 2007-2010 112
8.2.1 Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 112
8.2.2 Kimberly-Clark Completes Acquisition of I-Flow 113
8.2.3 Surmodics Acquires Brookwood Pharmaceuticals 114

9 Appendix 116
9.1 Definitions 116
9.1.1 Drug Delivery Devices 116
9.2 Acronyms 117
9.3 Research Methodology 118
9.3.1 Secondary Research 118
9.3.2 Primary Research 118
9.3.3 Models 119
9.3.4 Forecasts 119
9.3.5 Expert Panel 119
9.4 Contact Us 119
9.5 Disclaimer 120
9.6 Sources 120

List of Tables


Table 1: Drug Delivery Device Market, Global, Revenue ($m), 2003-2010 11
Table 2: Drug Delivery Device Market, Global, Revenue ($m), 2010-2017 12
Table 3: Drug Delivery Device Market, Global, Key Company Revenues ($m), 2010 22
Table 4: Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
Table 5: Central Venous Catheter Market, Global, Revenue ($m), 2010-2017 25
Table 6: Central Venous Catheter Market, Global, Key Company Revenues ($m), 2010 29
Table 7: Infusion System Market, Global, Revenue ($m), 2003-2010 30
Table 8: Infusion System Market, Global, Revenue ($m), 2010-2017 31
Table 9: Infusion System Market, Global, Key Company Revenues ($m), 2010 37
Table 10: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
Table 11: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2010-2017 39
Table 12: Metered Dose Inhaler Device Market, Global, Key Company Revenues ($m), 2010 43
Table 13: Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 45
Table 14: Needle-Free Injection Market, Global, Revenue ($m), 2010-2017 46
Table 15: Needle-Free Injection Market, Global, Key Company Revenues ($m), 2010 50
Table 16: Drug Delivery Device Market, Global, Cross-Country Analysis, CAGR (%), 2003-2017 51
Table 17: Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
Table 18: Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
Table 19: Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
Table 20: Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
Table 21: Drug Delivery Device Market, the UK, Revenue ($m), 2003-2010 56
Table 22: Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
Table 23: Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
Table 24: Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
Table 25: Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
Table 26: Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
Table 27: Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
Table 28: Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
Table 29: Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
Table 30: Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
Table 31: Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
Table 32: Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
Table 33: Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
Table 34: Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
Table 35: Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
Table 36: Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
Table 37: Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
Table 38: Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
Table 39: Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
Table 40: Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75
Table 41: Drug Delivery Systems, Global, Pipeline Products Summary, 2010 91
Table 42: Injectable Drug Delivery - List of Pipeline Products-1, 2011 92
Table 43: Injectable Drug Delivery - List of Pipeline Products-2, 2011 93
Table 44: Metered Dose Inhalers: List of Pipeline Products, 2010 95
Table 45: Infusion Systems - List of Pipeline Products, 2011 96
Table 46: Needle-Free Injections: List of Pipeline Products, 2010 98
Table 47: Peripherally Inserted Central Catheter - List of Pipeline Products, 2010 99
Table 48: Transdermal Drug Delivery Devices - List of Pipeline Products-I, 2011 100
Table 49: Transdermal Drug Delivery Devices - List of Pipeline Products-II, 2011 101
Table 50: Transmucosal Drug Delivery Devices - List of Pipeline Products, 2011 103
Table 51: Inhalable Drug Delivery Devices - List of Pipeline Products, 2011 105
Table 52: Niche Technologies - List of Pipeline Products, 2011 107
Table 53: Drug Delivery Device Market, Mergers & Acquisitions, by Number of Deals, Global, 2007-2010 109
Table 54: Drug Delivery Device Market, Mergers & Acquisitions, by Volume-1, Global, 2007-2010 110
Table 55: Drug Delivery Device Market, Mergers & Acquisitions, by Volume-2, Global, 2007-2010 111

List of Figures


Figure 1: Drug Delivery Device Market, Global, Revenue ($m), 2003-2010 11
Figure 2: Drug Delivery Device Market, Global, Revenue ($m), 2010-2017 12
Figure 3: Nanotechnology in Drug Delivery, Future Applications of Nanotechnology in Medical Devices, 2011 13
Figure 4: Drug Delivery Devices, Market Dynamics 17
Figure 5: Advantages of New Drug Delivery Technology, 2011 19
Figure 6: Drug Delivery Device Market, Global, Company Share (%), 2010 22
Figure 7: Drug Delivery Devices, Market Categorization and Segmentation 23
Figure 8: Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 24
Figure 9: Central Venous Catheter Market, Global, Revenue ($m), 2010-2017 25
Figure 10: Central Venous Catheters, Market Dynamics 26
Figure 11: Central Venous Catheter Market, Global, Company Share (%), 2010 29
Figure 12: Infusion System Market, Global, Revenue ($m), 2003-2010 30
Figure 13: Infusion System Market, Global, Revenue ($m), 2010-2017 31
Figure 14: Infusion Systems, Market Dynamics 32
Figure 15: Infusion System Market, Global, Company Share (%), 2010 37
Figure 16: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 38
Figure 17: Metered Dose Inhaler Device Market, Global, Revenue ($m), 2010-2017 39
Figure 18: Metered Dose Inhaler Devices, Market Dynamics 40
Figure 19: Metered Dose Inhaler Device Market, Global, Company Share (%), 2010 43
Figure 20: Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 44
Figure 21: Needle-Free Injection Market, Global, Revenue ($m), 2010-2017 46
Figure 22: Needle-Free Injections, Market Dynamics 47
Figure 23: Needle-Free Injection Market, Global, Company Share (%), 2010 50
Figure 24: Drug Delivery Device Market, Cross-Country Analysis, Global, CAGR (%), 2002-2016 51
Figure 25: Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 52
Figure 26: Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 53
Figure 27: Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 54
Figure 28: Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 55
Figure 29: Drug Delivery Device Market, UK, Revenue ($m), 2003-2010 56
Figure 30: Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 57
Figure 31: Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 58
Figure 32: Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 59
Figure 33: Drug Delivery Device Market, France, Revenue ($m), 2003-2010 60
Figure 34: Drug Delivery Device Market, France, Revenue ($m), 2010-2017 61
Figure 35: Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 62
Figure 36: Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 63
Figure 37: Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 64
Figure 38: Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 65
Figure 39: Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 66
Figure 40: Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 67
Figure 41: Drug Delivery Device Market, China, Revenue ($m), 2003-2010 68
Figure 42: Drug Delivery Device Market, China, Revenue ($m), 2010-2017 69
Figure 43: Drug Delivery Device Market, India, Revenue ($m), 2003-2010 70
Figure 44: Drug Delivery Device Market, India, Revenue ($m), 2010-2017 71
Figure 45: Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 72
Figure 46: Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 73
Figure 47: Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 74
Figure 48: Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 75
Figure 49: Drug Delivery Devices, Market Opportunities and Risk Evaluation, Global, by Segment 76
Figure 50: Drug Delivery Devices, Competitive Assessment, 2010 77
Figure 51: GlaxoSmithKline plc, SWOT Analysis, Drug Delivery Devices, Global, 2010 78
Figure 52: Boehringer Ingelheim GmbH, SWOT Analysis, Drug Delivery Devices, Global, 2010 79
Figure 53: AstraZeneca plc, SWOT Analysis, Drug Delivery Devices, Global, 2010 81
Figure 54: Hospira, Inc., SWOT Analysis, Drug Delivery Devices, Global, 2010 83
Figure 55: CareFusion, SWOT Analysis, Drug Delivery Devices, Global, 2010 85
Figure 56: Baxter International Inc, SWOT Analysis, Drug Delivery Devices, Global, 2010 87
Figure 57: Teleflex Incorporated, SWOT Analysis, Drug Delivery Devices, Global, 2010 89
Figure 58: INJEX Equidyne Systems, SWOT Analysis, Drug Delivery Devices, Global, 2010 90
Figure 59: Drug Delivery Systems, Global, Pipeline Products Summary, 2010 91
Figure 60: Drug Delivery Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 109

Upcoming Reports:

Gas Pooling Mechanism Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Gas pooling is a mechanism through which gas produced from domestic fields is pooled with Liquefied natural gas (LNG) in order to make gas affordable to anchor customers such as power and fertilizer sector. Over the past decade, India’s energy consumption has increased at a rapid rate. This has been primarily due to the growing economy and rising population.  Gas production from RIL’s KG D6 field catalyzed the power and fertilizer ministries to ensure adequate supply of gas to their sectors on priority basis. The key advantage of gas based power plants is that they...
AFP Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Alpha-fetoprotein (AFP) is the most widely found plasma protein in human fetus.  The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4.  It is a major plasma protein which is produced during fetal development in yolk sac and the liver.  AFP is a glycoprotein which is found in monomeric, dimeric and trimeric forms. The protein is normally made by immature liver cells in the fetus therefore; infants have higher levels of AFP, which falls to normal adult level by the end of first year.  Usually, low level of AFP protein is...
Hydrocolloids Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Hydrocolloids are those polymers that are readily soluble, dispersive and prone to swell in water and thus change the physical properties of the solution to form gels, or enable thickening, emulsification and/or stabilization. Xanthan, carrageenan, starches and other such naturally occurring substances are some common hydrocolloids used in the market today. Based on their application, hydrocolloids are used in food, oilfields, pharmaceutical, paper and board, textiles and other industries. The major application markets for hydrocolloids are food and oilfields, both by revenue and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Western Africa economies hit by Ebola travel ban
Aug 28, 2014  
With over 1,400 people dead due to the fatal Ebola outbreak in African countries, travel services have either banned or limited operations to the western region, severely hitting economies of the area. Budgetary resources are being utilized rapidly and economic growth has dropped by 4% as international projects and trips have been cancelled. Transport companies have cut off the region...
Fonterra Ties Up With Beingmate to Tap into China’s Baby Food Market
Aug 28, 2014  
Fonterra Co-Operative Group Ltd. will partner with Beingmate Group Co, China’s biggest infant formula manufacturer to increase its reach in the Chinese market. The New Zealand-based company makes this move with the intent to grab a bigger market share in China after it suffered many setbacks in the food-safety scandal last year.   This partnership will also help Beingmate...
Warren Buffet Helps Burger King with Tim Horton Deal
Aug 27, 2014  
Renowned investor Warren Buffet plans to finance Burger King Worldwide Inc.’s acquisition of Tim Hortons Inc., the Canadian coffee chain. Berkshire Hathaway Inc., Warren Buffet’s firm will invest through preferred shares, it is speculated. Nearly 25% of the deal’s financing would be handled by Berkshire. The precise aim for Warren Buffet’s participation is yet...
Anti-UAW Workers to Form Another Union at Volkswagen Plant
Aug 27, 2014  
Employees at the Chattanooga plant of Volkswagen AG are trying to form a union of company’s salaried and hourly workers, as a means to counter the United Auto Workers Local 42 union that was established last month.  The new union is expected to force Volkswagen in rethinking and holding another vote to determine which union is favored by hourly employees. UAV had earlier...
Fairchild Axing 15% of its Workforce with Multiple Plant Closures
Aug 27, 2014  
American semiconductor manufacturer Fairchild has said that it will be laying off nearly 15% of its global workforce following the closure of its facilities in Malaysia, Utah, and Korea. The company will cease the production of five-inch silicon from its plant in Bucheon, Korea. It will also scale down its capacity to produce six-inch wafers. The company will bring these closures into effect...